InforCapital
Startup Fundraising

WHOOP Raises $575M for Global Health Platform Expansion

WHOOP closes $575M Series G at $10.1B valuation to expand its personalized health platform globally, including a new R&D facility in Doha.

AM
Alvaro de la Maza

Partner at Aninver

Key Takeaways

  • WHOOP raised $575.0M (Series G) from Collaborative Fund, 2PointZero Group, Qatar Investment Authority, Mubadala Investment, Abbott, Mayo Clinic, Macquarie Capital, Glade Brook, BFlexion, IVP, Foundry, Accomplice, Affinity Partners, Bullhound Capital.
  • Sector: Healthcare, Healthtech & Medtech, Technology, Software & Gaming.
  • Geography: United States, Qatar, United Arab Emirates.

Analysis

WHOOP, a leader in personalized health monitoring, has successfully closed a substantial $575 million Series G funding round, propelling its valuation to an impressive $10.1 billion. This significant capital infusion is earmarked for aggressive global expansion, with a particular focus on the Gulf Cooperation Council (GCC) region, and the further development of its advanced preventive health platform.

The investment was spearheaded by Collaborative Fund and saw robust backing from key entities within the GCC, including the Qatar Investment Authority (QIA), Mubadala Investment Company, and 2PointZero Group. A diverse group of global investors also participated, underscoring broad confidence in WHOOP's mission. These include prominent names such as Abbott, the Mayo Clinic, Macquarie Capital, Glade Brook, BFlexion, IVP, Foundry, Accomplice, Affinity Partners, and Bullhound Capital. The round also attracted investment from globally recognized athletes and cultural figures, including Cristiano Ronaldo and LeBron James, highlighting the brand's deep integration with elite performance and wellness.

This funding arrives at a critical juncture for global health, as chronic diseases continue to rise and traditional healthcare systems grapple with reactive models. WHOOP's approach, leveraging continuous biometric data and AI, offers a paradigm shift towards predictive, personalized interventions. The company's platform, which has amassed over 2.5 million members worldwide, analyzes billions of hours of physiological data to provide actionable insights on sleep, recovery, and strain. In 2025 alone, WHOOP experienced a remarkable 103% year-over-year growth in bookings, concluding the year with a $1.1 billion run rate and achieving positive cash flow.

A cornerstone of WHOOP's international strategy will be the establishment of WHOOP Labs Doha, its inaugural international research and development facility. This move signifies a deep commitment to the GCC market and aims to foster innovation within the region's burgeoning performance science ecosystem. The company is actively expanding its global team, with over 600 new roles being created to support its ambitious growth and R&D objectives across the GCC, Europe, Latin America, and Asia.

The strategic importance of the GCC is further emphasized by Will Ahmed, Founder and CEO of WHOOP. He noted the region's forward-thinking approach to health, performance, and longevity, stating, "We're building real momentum on the ground, expanding our local teams and growing our retail footprint in multiple markets. We’re also developing meaningful partnerships across the region to integrate WHOOP into broader health and performance ecosystems. We’re committed to investing here for the long term."

WHOOP's platform differentiates itself through high user engagement, with members accessing the app an average of over eight times daily – significantly higher than other non-screen wearables. This frequent interaction allows users to gain a granular understanding of how daily habits impact their physiological state and long-term health, moving beyond basic fitness tracking to proactive health management and risk reduction.